Sheima Farag

[Aislinn M-D @aislinnmacklin]

The NHS will last as long as their are folk left to fight for it
Today your junior doctors were those folk✌️
Proud of my colleagues
#JuniorDoctorsStrike

[Sheima Farag @FaragSheima]

The picket line today at the Royal Marsden Hospital Fulham
Road 💪🏼💪🏼
#JuniorDoctorsStrike

[Lewis Au @lewisjwau]

🙏Thank you @Uroweb #EAU23 for the BEST PAPER ON FUNDAMENTAL RESEARCH AWARD @Cancer_Cell https://t.co/wqQfDTJlR1 (Open Access)🎉

Importantly, this is recognition for the huge team effort @royalmarsdenNHS @TurajlicLab @TheCrick @uclcancer & others 🙌over many yrs

Truly grateful.

[Mary O'Brien @drMaryOBr]

For easy access. 1st IA of Pearls/KN091, positive for DFS, stage 1b-3, all PDL1. @myESMO #oncoalert @EORTC @etop @btog @peters_solange https://t.co/MgTnriouz5

[UCL Cancer Institute @uclcancer]

New position available to join @NickyMcGranahan Lab at UCL. Seeking collaborative
 and self-motivated Research Fellow to work on cancer evolution - deciphering impact of treatment on acquisition of somatic alterations and immune microenvironment. ℹ️ https://t.co/rlIlBZJYFU

[VJ Oncology @VJOncology]

📢We discussed updates on the AUDURA trial investigating adjuvant osimertinib in patients with resected EGFRm stage IB–IIIA #NSCLC with @DrSanjayPopat at #ESMO22!

🎥Interview coming soon to https://t.co/ys1d8pDAKO - watch this space!

@myESMO #LungCancer #LCsm #TrialUpdate #CTSM

[ESMO - Eur. Oncology @myESMO]

#ESMO22:Sotorasib improves PFS versus docetaxel in patients with pre-treated KRAS G12C-mutated #NSCLC
👉https://t.co/wLAu8vtVDp
@APassaroMD @CharlesSwanton @mljohnsonmd

[ESMO - Eur. Oncology @myESMO]

At #ESMO22: impressive results from the NICHE-2 trial may open a way to a ‘watch and wait’ approach for patients with #dMMR #ColonCancer
👉https://t.co/pOw6uUONxO
@JenSeligmann @MyriamChalabi

[Sapna Patel @DrSapnaPatel]

Exciting indeed! Thank u for allowing @SWOG @NCICTEP_ClinRes to present results of #S1801 Improvement in event-free survival in #Neoadjuvant regimen of pembro 200mg q3wk➡️ surgery ➡️15 doses of pembro compared to surgery ➡️ 18 adjuvant doses of pembro in resectable melanoma

[Sanjay Popat @DrSanjayPopat]

Great chatting to folk at @VJOncology today about new thoracic data at #ESMO22 and impact on practice. Look out for the final cut! @myESMO

[Sheima Farag @FaragSheima]

@MyriamChalabi @HazelOSulliva14 @myESMO Thanks lovely Myriam! It was so so wonderful seeing you again! Also very lovely to see @lab_kok and the rest of the NKI crew. Really missed you and hope to see you again soon! Please come visit when in London!

[Sanjay Popat @DrSanjayPopat]

Indeed, delighted to be leading this forthcoming ctDNA pilot implementation with @AlastairGreyst2 - early upfront ctDNA NGS has huge potential to improve patient outcomes @CharuAggarwalMD @ChristianRolfo @UmbertoMalapel1

[Hazel O'Sullivan @HazelOSulliva14]

Well done @FaragSheima who found there was no difference in OS in NSCLC pts receiving ICI with DMII or hyperglycemia.@myESMO

[Professor Georgina Long AO (Bluesky @gvlongphdmd) @ProfGLongMIA]

NOW we must change the #melanoma management guidelines across the world. #Neoadjuvant #immunotherapy better than adjuvant in resectable stage 3&4 melanoma SWOG1801 HR 0.58 p0.004 fir event-free survial

[Sheima Farag @FaragSheima]

“This is a waterfall plot” Legendary presentation #ESMO22 delivered by @MyriamChalabi Congratulations! 💪🏼💪🏼🎉🎉🎉

[@cancernurseEU @cancernurseEU]

At #EONS15LUNG symposium ‘We are raising awareness of inequities re access to lung cancer treatment and care and improving lung cancer prevention, early detection, treatment and care,’ says speaker @nurseygerty #EONS15 #ESMO22 @KarabaticSandra @JoVick13 @silvija_p20 @JanssenUK

[Stephen V Liu, MD @StephenVLiu]

Great discussion of the immunotherapy abstracts by Dr. @drMaryOBr - note the delayed separation of survival curves with POSEIDON. We've seen similar patterns in other studies. #ESMO22

[Julien Mazieres @JulienMazieres]

ADAURA updated results nicely challenged by @DrSanjayPopat regarding the slope steepness in each stage. "curative" effect in early stage, "delaying" effect in 2/3 stages ? #ESMO22 @OncoAlert

[The Raila Odinga Amolo Foundation @RailaOdinga]

Congratulations Joyciline Jepkosgei on the fantastic run to win the #LondonMarathon. We are proud of you for flying our flag high. 🇰🇪

Well in!

Keep running and keep inspiring our upcoming athletes. Hongera!

[Vivek Subbiah, MD @VivekSubbiah]

Opposing roles of the immune system in tumors. Would this explain why some tumors have dramatic responses versus other Hyperprogression ? Fascinating @ScienceMagazine @weldeiry @Dr_R_Kurzrock https://t.co/221tCwKMcU